SFRP1 is negatively associated with cancer development and progression, and hypermethylation of SFRP1 promoter and transcription suppression [110] has been demonstrated for brain cancers of glial origin, such as glioma [140] and astrocytoma [112]. This evidence concerns the gene SFRP1 and glioma.